Pinocembrin

Pinocembrin is a dihydroflavonone compound found in honey, propolis, and certain plants that exhibits neuroprotective properties through antioxidant mechanisms. It modulates apoptotic pathways by inhibiting p53 expression and regulating Bax-Bcl-2 ratios in preclinical studies.

Origin & History

Pinocembrin is a flavanone flavonoid (5,7-dihydroxyflavanone) found naturally in diverse plants including Pinus heartwood, Eucalyptus, propolis, honey, fruits, vegetables, nuts, seeds, herbs, and spices. It is purified using chromatographic techniques or biosynthesized in microbes like E. coli using enzymes such as phenylalanine ammonia-lyase (PAL) and chalcone synthase (CHS).

Historical & Cultural Context

While pinocembrin is found in plants like damiana (Turnera diffusa) and yerba santa (Eriodictyon californicum) that have ethnobotanical associations, no specific traditional medicine uses or historical context for pinocembrin itself are documented in the research. The compound has general chemopreventive associations but lacks explicit traditional claims.

Health Benefits

• Neuroprotective effects demonstrated in preclinical models of cerebral ischemia/reperfusion injury (animal studies only)
• Antioxidant activity shown in laboratory studies (in vitro evidence)
• Anti-apoptotic effects via p53 inhibition and Bax-Bcl-2 ratio modulation (preclinical data)
• Potential anti-cancer properties including apoptosis induction and cell migration inhibition (in vitro studies)
• Vasodilatory effects observed in laboratory models (preclinical evidence)

How It Works

Pinocembrin exerts neuroprotective effects by scavenging reactive oxygen species and reducing oxidative stress in neural tissues. It inhibits p53-mediated apoptosis while modulating the Bax-Bcl-2 protein ratio to prevent programmed cell death. The compound also demonstrates anti-inflammatory activity through inhibition of pro-inflammatory cytokine release.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses have been conducted on pinocembrin according to available research. All current evidence is limited to preclinical studies using in vitro and animal models, particularly focused on neuroprotection in cerebral ischemia and glutamate injury models.

Clinical Summary

Current evidence for pinocembrin comes primarily from in vitro laboratory studies and animal models of cerebral ischemia-reperfusion injury. Preclinical studies have shown neuroprotective effects in rodent stroke models, but no human clinical trials have been conducted. The antioxidant activity has been demonstrated in cell culture studies using various oxidative stress markers. Evidence remains limited to preliminary research without human validation of therapeutic benefits.

Nutritional Profile

Pinocembrin (5,7-dihydroxyflavanone) is a flavanone with molecular weight ~256.25 g/mol, not a nutritional food source but a bioactive polyphenolic compound. Found naturally in propolis (concentrations ~10-30 mg/g of propolis extract), honey (trace amounts, ~0.5-5 mg/kg), ginger rhizomes, and various plant resins. As a flavanone, it contains two hydroxyl groups at positions 5 and 7 on the A-ring, responsible for its antioxidant capacity (ORAC values comparable to other dihydroxylated flavonoids). Bioavailability is relatively low due to rapid Phase II metabolism (glucuronidation and sulfation in the gut and liver); oral bioavailability estimated at ~3-5% in rodent models. Lipophilic character (LogP ~2.6) allows moderate membrane permeability and notable blood-brain barrier penetration, which underlies its neuroprotective research interest. No significant macronutrient, vitamin, or mineral content as it is consumed as an isolated compound or within propolis extracts, typically dosed at 10-100 mg in supplement form.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are available as no human trials have been conducted. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Pinocembrin pairs well with **Chrysin** (another propolis flavonoid, 50-200 mg) as both share the flavanone/flavone backbone and co-occur in propolis; chrysin enhances anti-inflammatory signaling via complementary NF-κB suppression while pinocembrin targets Nrf2/ARE antioxidant pathways. **Piperine** (5-20 mg, from black pepper) significantly improves pinocembrin's oral bioavailability by inhibiting CYP450 enzymes and intestinal glucuronidation, potentially boosting plasma levels 2-3 fold. **Caffeic acid phenethyl ester (CAPE)** (25-100 mg, also from propolis) synergizes by amplifying anti-apoptotic effects—CAPE targets NF-κB while pinocembrin modulates p53/Bax-Bcl-2, providing multi-pathway neuroprotection. **Curcumin** (200-500 mg, standardized extract) complements pinocembrin's antioxidant and anti-neuroinflammatory activity through shared modulation of MAPK and PI3K/Akt survival pathways, and both compounds benefit from co-administration with piperine for enhanced absorption.

Safety & Interactions

Safety data for pinocembrin supplementation in humans is extremely limited due to lack of clinical trials. No specific drug interactions have been documented, though theoretical interactions with anticoagulant medications may exist given its presence in propolis. Pregnant and breastfeeding women should avoid pinocembrin supplements due to insufficient safety data. Individuals with bee product allergies should exercise caution as pinocembrin is naturally found in honey and propolis.